AU2005205898B2 - Taurate formulated pigmented cosmetic composition exhibiting radiance with soft focus - Google Patents

Taurate formulated pigmented cosmetic composition exhibiting radiance with soft focus Download PDF

Info

Publication number
AU2005205898B2
AU2005205898B2 AU2005205898A AU2005205898A AU2005205898B2 AU 2005205898 B2 AU2005205898 B2 AU 2005205898B2 AU 2005205898 A AU2005205898 A AU 2005205898A AU 2005205898 A AU2005205898 A AU 2005205898A AU 2005205898 B2 AU2005205898 B2 AU 2005205898B2
Authority
AU
Australia
Prior art keywords
measured
angle
composition
ranging
watt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2005205898A
Other versions
AU2005205898A1 (en
AU2005205898B8 (en
Inventor
Prem Chandar
Marc Nicolaas Gerard De Mul
Brian John Dobkowski
Jack Polonka
Jeffrey William Rosevear
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever PLC
Original Assignee
Unilever PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever PLC filed Critical Unilever PLC
Publication of AU2005205898A1 publication Critical patent/AU2005205898A1/en
Publication of AU2005205898B2 publication Critical patent/AU2005205898B2/en
Application granted granted Critical
Publication of AU2005205898B8 publication Critical patent/AU2005205898B8/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/28Zirconium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8158Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • A61K8/8182Copolymers of vinyl-pyrrolidones. Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A61K8/894Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/413Nanosized, i.e. having sizes below 100 nm

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cosmetics (AREA)

Description

WO 2005/070384 PCT/EP2005/000436 1 TAURATE FORMULATED PIGMENTED COSMETIC COMPOSITION EXHIBITING RADIANCE WITH SOFT FOCUS The invention relates to compositions for improving the appearance of skin, particularly to provide good coverage over imperfections such as pores and uneven skin tone, while retaining a natural skin appearance.
Background to the Invention A matte effect is desired for users of color cosmetics. The matte finish overcomes the shiny effect engendered by greasy skin, particularly under hot and humid conditions. Absorbent fillers such as talc, silica, kaolin and other inorganic particulates have been used to achieve the effect by their optical properties.
Imperfect skin can be hidden in two ways through manipulation of light transmission. In the first, components of the color cosmetic may simply reflect light back toward the source. An alternative approach is referred to as achieving a soft focus effect. Here the incoming light is distorted by scattering (lensing). Components of the color cosmetic in this mechanism operate as lenses to bend and twist light into a variety of directions.
While it is desirable to hide imperfect skin through a matte effect, there is also a desire to achieve a healthy skin radiance. A cosmetic covering that is too opaque hides the skin under a paintlike coating. Imperfections are hidden but there is no radiance.
Where light transmission is insufficiently hindered, the opposite WO 2005/070384 PCT/EP2005/000436 2 occurs. Here the glow may be healthy but aesthetically displeasing skin topography and color may now be apparent.
US Patent 5,997,890 (Sine et US Patent 5,972,359 (Sine et and US Patent 6,174,533 B1 (SaNogueira, Jr.) are all directed to topical compositions to provide good coverage of skin imperfections. The solution proposed by these documents is the use of a metal oxide with a refractive index of at least about 2 and a neat primary particle size of from about 100 to about 300 nm.
Preferred particulates are titanium dioxide, zirconium oxide and zinc oxide.
Silicone gelling agents such as crosslinked organopolysiloxane elastomers because of their excellent skinfeel properties have been found useful in make-up compositions. For instance, US Patent 5,266,321 (Shukuzaki et al.) discloses an oily make-up composition comprised of a silicone gel crosslinked elastomer, titanium dioxide, mica and iron oxides. Japanese patent application 61-194009 (Harashima) describes a make-up composition comprising a cured organopolysiloxane elastomer powder and pigments which may be selected from talc, titanium dioxide, zinc oxide and iron oxides.
A challenge which has not been fully met by the known art is delivery of a composition with appropriate optics to achieve both soft focus and radiance properties in a system that still provides excellent skinfeel.
P PDOCSVSLC\Spski 26S6VOI _Uni1"v_2.dSPA dm 00
O
-3- Summary of the Invention A cosmetic composition is provided which includes: 00 a crosslinked silicone elastomer; 00 5 (ii) a zinc oxide or zirconium oxide of average particle size less than 300 nm; S(iii) a taurate polymer; and t (iv) a cosmetically acceptable carrier system As now claimed, according to one aspect the present invention provides a cosmetic composition comprising: a crosslinked silicone elastomer; (ii) a zinc oxide or zirconium oxide of average particle size less than 300 nm; (iii) a taurate polymer; and (iv) a light reflecting inorganic platelet-shaped particle selected from titanium dioxide coated mica or bismuth oxychloride and having an average particle size of 10,000 to 30,000 nm; and a cosmetically acceptable carrier system.
As now claimed, according to one aspect the present invention provides a cosmetic composition comprising: from 0.01 to 30% of a crosslinked silicone elastomer by weight of the composition; (ii) from 0.1 to 20% of a zinc oxide by weight of the composition, the zinc oxide having an average particle size less than 300 nm; (iii) from 0.001 to 10% of a taurate polymer by weight of the composition; (iv) a light reflecting inorganic platelet-shaped particle selected from titanium dioxide coated mica or bismuth oxychloride and having an average particle size of 10,000 to 30,000 nm; a cosmetically acceptable carrier system; and wherein the composition has a Transmission Intensity of 4 to 7 million watt-nm/cm 2 measured at an angle of a Transmission Intensity ranging from 1 to 2 million watt- P \WPDOCSSI.C\SpC s2686O01_Unlcvc_2ndSPA doc 00 S-3Anm/cm 2 measured at a 100 angle; a Transmission Intensity ranging from 120 to 140
C
thousand watt-nm/cm 2 measured at a 300 angle; a Transmission Intensity ranging from to 80 thousand watt-nm/cm 2 measured at a 400 angle; and a Transmission Intensity ranging 00 from 40 to 60 thousand watt-nm/cm 2 measured at a 500 angle.
00 0 Detailed Description of the Invention Ni Now it has been observed that a soft focus effect with radiance can be obtained by a combination of fine particle sized zinc oxide or zirconium oxide suspended with a crosslinked silicone elastomer. The zinc oxide or zirconium oxide must have an average particle size less than 300 nm. Absent the elastomer or the oxide, there would be insufficient soft focus effect. Oxide alone is inefficient because of excessive loss of reflectance/radiance.
WO 2005/070384 PCT/EP2005/000436 4 Crosslinked Silicone Elastomer A component of the present invention is a crosslinked silicone (organopolysiloxane) elastomer. No specific restriction exists as to the type of curable organopolysiloxane composition that can serve as starting material for the crosslinked silicone elastomer. Examples in this respect are addition reactioncuring organopolysiloxane compositions which cure under platinum metal catalysis by the addition reaction between SiH-containing diorganopolysiloxane and organopolysiloxane having siliconbonded vinyl groups; condensation-curing organopolysiloxane compositions which cure in the presence of an organotin compound by a dehydrogenation reaction between hydroxyl terminated diorganopolysiloxane and SiH-containing diorganopolysiloxane; condensation-curing organopolysiloxane compositions which cure in the presence of an organotin compound or a titanate ester, by a condensation reaction between an hydroxyl terminated diorganopolysiloxane and a hydrolyzable organosilane (this condensation reaction is exemplified by dehydration, alcoholliberating, oxime-liberating, amine-liberating, amideliberating, carboxyl-liberating, and ketone-liberating reactions); peroxide-curing organopolysiloxane compositions which thermally cure in the presence of an organoperoxide catalyst; and organopolysiloxane compositions which are cured by high-energy radiation, such as by gamma-rays, ultraviolet radiation, or electron beams.
Addition reaction-curing organopolysiloxane compositions are preferred for their rapid curing rates and excellent uniformity WO 2005/070384 PCT/EP2005/000436 of curing. A particularly preferred addition reaction-curing organopolysiloxane composition is prepared from: an organopolysiloxane having at least 2 lower alkenyl groups in each molecule; an organopolysiloxane having at least 2 silicon-bonded hydrogen atoms in each molecule; and a platinum-type catalyst.
The crosslinked siloxane elastomer of the present invention may either be an emulsifying or non-emulsifying crosslinked organopolysiloxane elastomer or combinations thereof. The term "non-emulsifying," as used herein, defines crosslinked organopolysiloxane elastomer from which polyoxyalkylene units are absent. The term "emulsifying," as used herein, means crosslinked organopolysiloxane elastomer having at least one polyoxyalkylene polyoxyethylene or polyoxypropylene) unit.
Particularly useful emulsifying elastomers are polyoxyalkylenemodified elastomers formed from divinyl compounds, particularly siloxane polymers with at least two free vinyl groups, reacting with Si-H linkages on a polysiloxane backbone. Preferably, the elastomers are dimethyl polysiloxanes crosslinked by Si-H sites on a molecularly spherical MQ resin.
Preferred silicone elastomers are organopolysiloxane compositions available under the INCI names of dimethicone/vinyl dimethicone crosspolymer, dimethicone crosspolymer and Polysilicone-ll. Ordinarily these materials are provided as a 1-30% crosslinked silicone elastomer dissolved or suspended in a WO 2005/070384 PCT/EP2005/000436 6 dimethicone fluid (usually cyclomethicone). For purposes of definition "crosslinked silicone elastomer" refers to the elastomer alone rather than the total commercial compositions which also include a solvent dimethicone) carrier.
Dimethicone/vinyl dimethicone crosspolymers and dimethicone crosspolymers are available from a variety of suppliers including Dow Corning (9040, 9041, 9045, 9506 and 9509), General Electric (SFE 839), Shin Etsu (KSG-15, 16, 18 [dimethicone/phenyl vinyl dimethicone crosspolymer]), and Grant Industries (Gransil" line of materials), and lauryl dimethicone/vinyl dimethicone crosspolymers supplied by Shin Etsu KSG-31, KSG-32, KSG-41, KSG-42, KSG-43, and KSG-44).
Other suitable commercially available silicone elastomer powders include vinyl dimethicone/methicone silesquioxane crosspolymers from Shin-Etsu sold as KSP-100, KSP-101, KSP-102, KSP-103, KSP- 104, KSP-105, and hybrid silicone powders that contain a fluoroalkyl group or a phenyl group sold by Shin-Etsu as respectively KSP-200 and KSP-300.
The crosslinked silicone elastomers of the present invention may range in concentration from about 0.01 to about 30%, preferably from about 0.1 to about 10%, optimally from about 0.5 to about 2% by weight of the cosmetic composition. These weight values exclude any solvent such as cyclomethicone found in commercial "elastomer" silicones such as the Dow Corning products 9040 and 9045. For instance, the amount of crosslinked silicone elastomer in 9040 and 9045 is between 12 and 13% by weight.
WO 2005/070384 PCT/EP2005/000436 7 Most preferred as the silicone elastomer is 9045 which has a cyclomethicone swelled elastomer particle size (based on volume and calculated as spherical particles) which averages about 38 micron, and may range from about 25 to about 55 micron.
Micronized Zinc or Zirconium Oxide A second important component of the present invention is that of a micronized zinc oxide or zirconium oxide having average (number) particle sizes less than 300 nm, preferably less than 200 nm, more preferably less than 100 nm and optimally less than 85 nm. Generally the particle sizes can range from about 0.01 to about 280 nm, more preferably from about 1 to about 200 nm, even more preferably from 10 to 95 nm, and optimally from 25 to nm.
Average particle size for zinc oxide or zirconium oxide assumes a spherical shape and is defined as the diameter of the particle averaged over many particles. The average value is a number average. For spherical particles such as the zinc oxide, laser light scattering is utilized to determine the individual sizes of the particles and generate a particle size distribution plot.
Based upon the distribution plot, the average particle size can be determined. In more mathematical terms, the average particle size is a diameter converted from the meso-pore specific surface area determined by the t-plot method (particle size converted excluding the specific surface area of micro pores of less than 20 Angstrom). In detail, the average particle size D, assuming the particle as spherical form, can be obtained by the following WO 2005/070384 PCT/EP2005/000436 8 equation: D=6/pS, where S (m 2 represents a meso-pore specific surface area and p(g/cm) is the density.
The amount of the oxide may range from about 0.1 to about preferably from about 0.5 to about 10%, optimally from about 1 to about 5% by weight of the cosmetic composition.
Since the zinc oxide or zirconium oxide particles are applied to skin, it is desirable that they be free of toxic trace metal contaminants. A particularly preferred zinc oxide has trace concentrations of lead (less than 20 ppm), arsenic (less than 3 ppm), cadmium (less than 15 ppm) and mercury (less than 1 ppm).
This material is commercially available from BASF Corporation under the trademark of Z-Cote HP1. These particles are best delivered to the formula as a pre-mix of 5-80% weight by weight suspended in an organic ester base.
Zinc oxide or zirconium oxide particles of the present invention advantageously but not necessarily are substantially spherical in shape. The refractive index of these particles may preferably range from about 1.8 to about 2.3. Measurement of refractive index can be performed according to a method described in J.A. Dean, Ed., Lange's Handbook of Chemistry, 14 th Ed., McGraw Hill, New York 1992, Section 9, Refractometry, incorporated herein by reference.
Taurate Polymer A further important component of the invention will be an associative polymer. Particularly preferred are taurate WO 2005/070384 PCT/EP2005/000436 9 homopolymers and copolymers. The copolymers are especially useful wherein the taurate repeating monomer unit is acryloyl dimethyl taurate (in either free acid or salt form). Monomers forming the copolymer with taurate may include: styrene, acrylic acid, methacrylic acid, vinyl chloride, vinyl acetate, vinyl pyrrolidone, isoprene, vinyl alcohol, vinyl methylether, chloro-styrene, dialkylamino-styrene, maleic acid, acrylamide, methacrylamide and mixtures thereof. Where the term "acid" appears, the term means not only the free acid but also Ci-C 30 alkyl esters, anhydrides and salts thereof. Preferably but not exclusively the salts may be ammonium, alkanolammonium, alkali metal and alkaline earth metal salts. Most preferred are the ammonium and alkanolammonium salts.
Examples of suitable taurate polymers are those listed in the Table below.
Supplier Name INCI Name Clariant Aristoflex AVC A~mmonium acryloyldimethyltaurate/VP copolymer Clariant Aristotlex lIMB Amnmonium. acryloyldimethyltaurate/beheneth-25 methacrylate crosspolymer Clariant Hostacerin AMPS Ammonium polyacryloyldimethyl taurate RITA Viscolam. SMC 20 Sodium acrylate/sodium acryloyldi-metayl taurate copolymer and C13-C14 isoparaf fin and laureth- 8 SEPPIC Simulgel 600 Acrylamide/sodiun acryloyldimethyltaurate copolymer; isohexadecane;. polysorbate SEPLC Simulgel 800 sodium polyacryloyldimethyl taurate, isohexadecane; sorbitan oleate SEPPIC SiMulgel EQ Sodium acrylate/acryloyldimethyl taurate copolymer and isohexadecane and polysorbate SEPPIC Simulgel EPG Sodium acrylate/acryloyldimethyl taurate copolymer and polyisobutene and caprylyl/capryl glucoside SEPPIC Simulgel NS Hydroxyethyl acrylate/sodium acryloyldimethyl taurate Copolymer and squalane and WO 2005/070384 PCT/EP2005/000436 Most preferred as the copolymer is Acryloyl Dimethyltaurate/Vinyl Pyrrolidone Copolymer, which is the INCI nomenclature, for a material supplied by Clariant Corporation under the trademark Aristoflex® AVC, having the following general formula: 0 NH O
H
3
C
H
3 C CH,
SONH
4 wherein n and m are integers which may independently vary from 1 to 10,000.
Number average molecular weight of taurate polymers according to the invention may range from about 1,000 to about 3,000,000, preferably from about 3,000 to about 100,000, optimally from about 10,000 to about 80,000.
Amounts of the taurate polymer may range from about 0.001 to about 10%, preferably from about 0.01 to about more preferably from about 0.1 to about optimally from about 0.2 to about 1% by weight of the composition.
WO 2005/070384 PCT/EP2005/000436 Optional Particles Another desirable component of compositions according to the present invention is that of a light reflecting platelet shaped particles. These particles will have an average particle size
D
50 ranging from about 10,000 to about 30,000 nm. The refractive index of these particles are preferred to be at least about 1.8, generally from about 1.9 to about 4, more preferably from about 2 to about 3, optimally between about 2.5 and 2.8.
Illustrative but not limiting examples of light reflecting particles are bismuth oxychloride (single crystal platelets) and titanium dioxide coated mica. Suitable bismuth oxychloride crystals are available from EM Industries, Inc. under the trademarks Biron® NLY-L-2X CO and Biron® Silver CO (wherein the platelets are dispersed in castor oil); Biron® Liquid Silver (wherein the particles are dispersed in a stearate ester); and Nailsyn® IGO, Nailsyn® II C2X and Nailsyn® II Platinum (wherein the platelets are dispersed in nitrocellulose). Most preferred is a system where bismuth oxychloride is dispersed in a C 2
-C
40 alkyl ester such as in Biron® Liquid Silver.
Among the suitable titanium dioxide coated mica platelets are materials available from EM Industries, Inc. These include Timiron® MP-10 (particle size range 10,000-30,000 nm), Timiron® MP-14 (particle size range 5,000-30,000 nm), Timiron® (particle size range 2,000-20,000 nm), Timiron® MP-101 (particle size range 5,000-45,000 nm), Timiron® MP-111 (particle size range 5,000-40,000 nm) Timiron® MP-1001 (particle size range 5,000-20,000 nm) Timiron® MP-155 (particle size range 10,000- WO 2005/070384 PCT/EP2005/000436 13 40,000 nm), Timirone MP-175 (particle size range 10,000-40,000), Timirone MP-115 (particle size range 10,000-40,000 nm), and Timiron® MP-127 (particle size range 10,000-40,000 nm). Most preferred is Timiron® MP-111. The weight ratio of titanium dioxide coating to the mica platelet may range from about 1:10 to about 5:1, preferably from about 1:1 to about 1:6, more preferably from about 1:3 to about 1:4 by weight.
Advantageously the preferred compositions will generally be substantially free of titanium dioxide outside of that required for coating mica.
Coatings for mica other than titanium dioxide may also be suitable. Silica coatings are such an alternative.
The amount of the light reflecting platelet shaped particles may range from about 0.1 to about preferably from about 0.5 to about more preferably from about 0.8 to about optimally from about 1 to about 1.5% by weight of the composition.
Advantageously compositions of the present invention will have a Reflectance Intensity as measured at a 300 angle ranging from 140 to 170 thousand Watt-nm/cm 2 Light Transmission Intensity advantageously ranges from 4 to 7 million Watt-nm/cm 2 at an angle of a Transmission Intensity ranging from 1 to 2 million Watt-nm/cm 2 at a 100 angle; a Transmission Intensity ranging from 120 to 140 thousand Watt-nm/cm 2 at a 300 angle; a Transmission Intensity ranging from 60 to 80 thousand Wattnm/cm 2 at a 40° angle; and a Transmission Intensity ranging from to 60 thousand Watt-nm/cm 2 at a 500 angle.
WO 2005/070384 PCT/EP2005/000436 Advantageously the weight ratio of zinc oxide and zirconium oxide to light reflecting platelet shaped particles may range from about 4:1 to about 1:1, preferably from about 3:1 to about 1.5:1, optimally about 2:1 by weight. In a preferred but not limiting example, the amount of silicone elastomer and oxide particles relative to the light reflective platelet shaped particles may be present in a ratio from about 10:1 to about 1:1, preferably from about 6:1 to about 1:1, more preferably from about 5:1 to about 3:1, optimally about 4:1 by weight.
Advantageously compositions of the present invention may include a non-coated mica. These mica particles can also be platelets but of thinner and smaller particle size than the coated micas mentioned above. Particularly preferred is Satin Mica, available from Merck-Rona. These are useful to remove any excessive glitter imparted by the light scattering platelets.
Advantageously the particle size of the non-coated mica is no higher than 15,000 nm and an average (volume) particle size ranging from 1,000 to 10,000 nm, preferably from 5,000 to 8,000 nm.
The amount of the non-coated mica may range from about 0.05 to about preferably from about 0.1 to about optimally from about 0.4 to about 0.8% by weight of the composition.
Advantageously present may also be water-insoluble organic material in the form of polymeric porous spherical particles. By the term "porous" is meant an open or closed cell structure. Preferably the particles are not hollow beads. Average particle size may range from about 0.1 to about 100, preferably from about 1 to about WO 2005/070384 PCT/EP2005/000436 more preferably greater than 5 and especially from 5 to about optimally from about 6 to about 10 um. Organic polymers or copolymers are the preferred materials and can be formed from monomers including the acid, salt or ester forms of acrylic acid and methacrylic acid, methylacrylate, ethylacrylate, ethylene, propylene, vinylidene chloride, acrylonitrile, maleic acid, vinyl pyrrolidone, styrene, butadiene and mixtures thereof. The polymers are especially useful in cross-linked form. Cells of the porous articles may be filled by a gas which can be air, nitrogen or a hydrocarbon. Oil Absorbance (castor oil) is a measure of porosity and in the preferred but not limiting embodiment may range from about 90 to about 500, preferably from about 100 to about 200, optimally from about 120 to about 180 ml/100 grams. Density of the particles in the preferred but not limiting embodiment may range from about 0.08 to 0.55, preferably from about 0.15 to 0.48 g/cm 3 Illustrative porous polymers include polymethylmethacr-ylate and cross-linked polystyrene. Most preferred is polymethyl methacrylate available as Ganzpearl® GMP 820 available from Presperse, Inc., Piscataway, New Jersey, known also by its INCI name of Methyl Methacrylate Crosspolymer.
Amounts of the water-insoluble polymeric porous particles may range from about 0.01 to about 10%, preferably from about 0.1 to about optimally from about 0.3 to about 2% by weight of the composition.
Carrier System and Optional Components A crystalline structurant advantageously may be present in compositions according to the present invention. The structurant may include both a surfactant and a co-surfactant. The nature of the WO 2005/070384 PCT/EP2005/000436 16 surfactant and co-surfactant will depend upon whether the crystalline structurant is anionic or nonionic. For structurants that are anionic, the preferred surfactants are C 1 0 -C22 fatty acids and salts soap) thereof and particularly combinations of these materials. Typical counterions forming the fatty acid salt are those of ammonium, sodium, potassium, lithium, trialkanolammonium triethanolammonium) and combinations thereof. Amounts of the fatty acid to the fatty acid salt when both present may range from about 100:1 to about 1:100, preferably from about 50:1 to about 1:50, and optimally from about 3:1 to about 1:3 by weight.
Illustrative fatty acids include behenic acid, stearic acid, isostearic acid, myristic acid, lauric acid, linoleic acid, oleic acid, hydroxystearic acid and combinations thereof. Most preferred is stearic acid. Among the fatty acid salts the most preferred is sodium stearate.
The co-surfactant for an anionic crystalline structurant typically is a C 10
-C
22 fatty alcohol, a C 1
-C
2 00 oo ester of a Clo-C 2 2 fatty acid and particularly combinations of these materials. Relative amounts of the ester to the alcohol when both present may range from about 100:1 to about 1:100, preferably from about 50:1 to about 1:50, and optimally from about 3:1 to about 1:3 by weight. Typical fatty alcohols include behenyl alcohol, stearyl alcohol, cetyl alcohol, myristyl alcohol, lauryl alcohol, oleyl alcohol and combinations thereof. Esters of the fatty acid preferably are polyol esters such as C 2
-C
3 alkoxylated alcohol esters. Among these are the polyethoxy, polypropoxy and block polyethoxy/polypropoxy alcohol esters. Particularly preferred are such esters as PEG-100 stearate, WO 2005/070384 PCT/EP2005/000436 stearate, PEG-80 laurate, PEG-20 laurate, PEG-100 palmitate, palmitate and combinations thereof.
The relative amount of surfactant and co-surfactant for the anionic structurant may range from about 50:1 to about 1:50, preferably from about 10:1 to about 1:10, and optimally from about 3:1 to about 1:3 by weight.
Nonionic type crystalline structurant will have a surfactant and a co-surfactant different than that for the anionic systems.
Preferred nonionic structurant surfactants are Ci-C 200 esters of C.o-
C
2 2 fatty acid. Esters of the fatty acid preferably are polyol esters such as C 2
-C
3 alkoxylated alcohol or sorbitol esters. Among these are the polyethoxy, polypropoxy and block polyethyoxy/polypropoxy alcohol esters. Particularly preferred are such esters as Polysorbate 40, Polysorbate 60, PEG-100 stearate, PEG-20 stearate, PEG-80 laurate, PEG-20 laurate, PEG-100 palmitate, palmitate and combinations thereof.
The co-surfactant of a nonionic structurant typically may be a combination of a CL0-C22 fatty alcohol, glyceryl esters of a C 10
-C
22 fatty acid, and a C 1 o-C 22 unesterified fatty acid. Relative amounts of the ester to the alcohol may range from about 100:1 to about 1:100, preferably from about 50:1 to about 1:50, and optimally from about 3:1 to about 1:3 by weight. Relative amounts of the combination of glyceryl ester and fatty alcohol to unesterified fatty acid may range from about 100:1 to about 1:100, preferably from about 50:1 to about 1:50, and optimally from about 3:1 to about 1:3 by weight. Typical fatty alcohols include behenyl alcohol, WO 2005/070384 PCT/EP2005/000436 18 stearyl alcohol, cetyl alcohol, myristyl alcohol, lauryl alcohol, oleyl alcohol and combinations thereof.
The relative amount of surfactant and co-surfactant in a nonionic structurant may range from about 50:1 to about 1:50, preferably from about 10:1 to about 1:10, and optimally from about 3:1 to about 1:3 by weight.
A crystalline structurant is formed by the surfactant and cosurfactant. Indeed, the surfactant and co-surfactant combination in their relative ratio and type of material is defined by an enthalpy which may range from about 2 to about 15, preferably from about to about 12, and optimally from about 3.5 to about 8 Joules per gram, as measured by Differential Scanning Calorimetry.
Furthermore, the crystalline structurant system advantageously may have a melting point ranging from about 30 to about 70°C, preferably from about 45 to about 65 0 C, and optimally from about 50 to about 0
C.
Normal forces which are positive numbers reflect a silky smooth skin feel of the formulation. Negative values have been identified with a draggy feel which many consumers dislike. Normal force is measured in the following manner. A rheometer that has a shear rate mode capability and a normal force transducer is utilized to measure the high shear normal force. These devices are available from Rheometric Scientific ARES, TA Instruments AR2000, and Paar Physica MCR. Samples are compressed between concentric parallel plates of diameter 25 mm and gap (vertical distance between the two plates) of 100 microns. The measurements are made in a continuous logarithmic shear sweep mode with a shear rate range of 1 to 10,000 s 1 Each WO 2005/070384 PCT/EP2005/000436 19 sweep takes 5 minutes and is conducted at ambient condition 0 The normal force is calculated by subtracting the baseline (defined as the normal force value at or near 100 s 1) from the highest normal force value measured between 1000 and 10,000 s 1
A
positive normal force of 5 grams and especially 10 grams or greater is correlated to products/materials with silky sensations during rubbing in application.
The higher the positive value of the normal force the better is the soft focus effect. Ordinarily, soft focus is enhanced when the normal force ranges from about +5 to about +100 grams. Particularly desirable is a positive normal force in the range from about +10 to about +60, optimally from about +25 to about +40 grams.
A variety of other components may be present in the compositions of the present invention. Foremost is that of water which serves as a carrier in the carrier system. Amounts of water may range from about 1 to about 90%, preferably from about 30 to about optimally from about 50 to about 80% by weight of the composition.
Emollient materials may be included as carriers in compositions of this invention. These may be in the form of silicone oils, synthetic esters and hydrocarbons. Amounts of the emollients may range anywhere from about 0.1 to about 95%, preferably between about 1 and about 50% by weight of the composition.
Silicone oils may be divided into the volatile and nonvolatile variety. The term "volatile" as used herein refers to those materials which have a measurable vapor pressure at ambient temperature (20-25 0 Volatile silicone oils are preferably chosen WO 2005/070384 PCT/EP2005/000436 from cyclic (cyclomethicone) or linear polydimethylsiloxanes containing from 3 to 9, preferably from 4 to 5, silicon atoms.
Nonvolatile silicone oils useful as an emollient material include polyalkyl siloxanes, polyalkylaryl siloxanes and polyether siloxane copolymers. The essentially nonvolatile polyalkyl siloxanes useful herein include, for example, polydimethyl siloxanes with viscosities of from about 5 x 10 6 to 0.1 m 2 /s at 25 0 C. Among the preferred nonvolatile emollients useful in the present compositions are the polydimethyl siloxanes having viscosities from about 1 x 10-5 to about 4 x 10- 4 m 2 /s at 25 0
C.
Among the ester emollients are: Alkenyl or alkyl esters of fatty acids having 10 to 20 carbon atoms. Examples thereof include isoarachidyl neopentanoate, isononyl isonanonoate, oleyl myristate, oleyl stearate, and oleyl oleate.
Ether-esters such as fatty acid esters of ethoxylated fatty alcohols.
Polyhydric alcohol esters. Ethylene glycol mono and di-fatty acid esters, diethylene glycol mono- and di-fatty acid esters, polyethylene glycol (200-6000) mono- and di-fatty acid esters, propylene glycol mono- and di-fatty acid esters, polypropylene glycol 2000 monooleate, polypropylene glycol 2000 rnonostearate, ethoxylated propylene glycol monostearate, glyceryl mono- and difatty acid esters, polyglycerol poly-fatty esters, ethoxylated glyceryl mono-stearate, 1,3-butylene glycol monostearate, 1,3- WO 2005/070384 PCT/EP2005/000436 21 butylene glycol distearate, polyoxyethylene polyol fatty acid ester, sorbitan fatty acid esters, and polyoxyethylene sorbitan fatty acid esters are satisfactory polyhydric alcohol esters. Particularly useful are pentaerythritol, trimethylolpropane and neopentyl glycol esters of C 1
-C
30 alcohols.
Wax esters such as beeswax, spermaceti wax and tribehenin wax.
Sterols esters, of which cholesterol fatty acid esters are examples thereof.
Sugar ester of fatty acids such as sucrose polybehenate and sucrose polycottonseedate.
Hydrocarbons which are suitable cosmetically acceptable carriers include petrolatum, mineral oil, C 11 -C13 isoparaffins, polyalphaolefins, and especially isohexadecane, available commercially as Permethyl 101A from Presperse Inc.
Humectants of the polyhydric alcohol-type can be employed as cosmetically acceptable carriers. Typical polyhydric alcohols include polyalkylene glycols and more preferably alkylene polyols and their derivatives, including propylene glycol, dipropylene glycol, polypropylene glycol, polyethylene glycol and derivatives thereof, sorbitol, hydroxypropyl sorbitol, hexylene glycol, 1,3butylene glycol, isoprene glycol, 1,2,6-hexanetriol, ethoxylated glycerol, propoxylated glycerol and mixtures thereof. The amount of humectant may range anywhere from 0.5 to 50%, preferably between 1 and 15% by weight of the composition. Most preferred is glycerol (also known as glycerin). Amounts of glycerin may range from about WO 2005/070384 PCT/EP2005/000436 22 to about 50%0, preferably from 12 to 35%0, optimally from 15 to by weight of the composition.
Sunscreen actives may also be included in compositions of the present invention. These will be organic compounds having at least one chromophoric group absorbing within the ultraviolet ranging from 290 to 400 nm. Chromophoric organic sunscreen agents may be divided into the following categories (with specific examples) including: paminobenzoic acid, its salts and its derivatives (ethyl, isobutyl, glyceryl esters; p-dimethylaminobenzoic acid), anthranilates (oaminobenzoates; methyl, menthyl, phenyl, benzyl, phenylethyl, linalyl, terpinyl, and cyclohexenyl esters); salicylates (octyl, amyl, phenyl, benzyl, menthyl, glyceryl, and dipropyleneglycol esters); cinnamic acid derivatives (menthyl and benzyl esters, alpha-phenyl cinnamonitrile; butyl cinnamoyl, pyruvate), dihydroxycinnamic acid derivatives (umbelliferone, methylumbelliferone, methylaceto-umbelliferone); trihydroxycinnamic acid derivatives (esculetin, methylesculetin, dapbnetin, and the glucosides, esculin and daphnin); hydrocarbons (diphenylbutadiene, stilbene); dibenzalacetone and benzalacetophenone; naphthol sulf onates (sodium salts of 2 -naphthol 6-disulf onic and of 2 -naphthol- 6, 8-disulf onic acids); dihydroxy-naphthoic acid and its salts; o- and p-hydroxybiphenyldisulfonates; coumarin derivatives (7-hydroxy, 7-methyl, 3-phenyl), diazoles (2-acetyl-3-bromoindazole, phenyl benzoxazole, methyl napbthoxazole, various aryl benzothiazoles), quinine salts (bisulf ate, sulfate, chloride, oleate, and tannate); quinoline derivatives (8-hydroxyquinoline salts, 2-phenylquinoline); hydroxy- or methoxy-substituted benzophenones; uric and vilouric acids, tannic acid and its WO 2005/070384 PCT/EP2005/000436 23 derivatives hexaethylether); (butyl carbityl) (6-propyl piperonyl) ether, hydroguinone; benzophenones (oxybenzone, sulisobenzone, dioxybenzone, benzoresorcinol, 2,2' tetrahydroxybenzophenone, 2,2' -dihydroxy- 4,4' -dimethoxybenzophenone, octabenzone; 4- isopropyldibenzoylmethane; butylmethoxydibenzoylmethane; etocrylene; and 4- isopropyldibenzoylmethane). Particularly useful are: 2-ethyihexyl pmethoxycinnamate, 4,4' -t-butyl methoxydibenzoylmethane, 2-hydroxy-4methoxybenzophenone, octyldimethyl p-aminobenzoic acid, digalloyltrioleate, 2, 2-dihydroxy-4-methoxybenzophenone, ethyl 4- £bis (hydroxypropyl)] aminobenzoate, 2-ethylhexyl-2-cyano-3, 3diphenylacrylate, 2-ethyihexylsalicylate, glyceryl p-aminobenzoate, 3,3, 5-trimethylcyclohexylsalicylate, methylanthranilate, p dimethylaminobenzoic acid or aminobenzoate, 2-ethyihexyl pdimethylaminobenzoate, 2 -phenylbenzimidazole-5-sulfonic acid, 2- (pdimethylaminophenyl) -5-sultoniobenzoxazoic acid and mixtures thereof.
Particularly preferred are such materials as ethylhexyl pmethoxycinnamate, available as Parsol MCXO), Avobenzene, available as Parsol 17890, and Dermablock OS® (octylsalicylate).
Amounts of the organic sunscreen agent will range from about 0.1 to about 15%, preferably from about 0.5%0 to about 10%, optimally from about 1% to about 8% by weight of the composition.
Preservatives can desirably be incorporated into the cosmetic compositions of this invention to protect against the growth of potentially harmful microorganisms. Suitable traditional preservatives for compositions of this invention are alkyl esters of para-hydroxybenzoic acid. Other preservatives which have more WO 2005/070384 PCT/EP2005/000436 recently come into use include hydantoin derivatives, propionate salts, and a variety of quaternary ammonium compounds. Cosmetic chemists are familiar with appropriate preservatives and routinely choose them to satisfy the preservative challenge test and to provide product stability. Particularly preferred preservatives are phenoxyethanol, methyl paraben, propyl paraben, imidazolidinyl urea, sodium dehydroacetate and benzyl alcohol. The preservatives should be selected having regard for the use of the composition and possible incompatibilities between the preservatives and other ingredients in the emulsion. Preservatives are preferably employed in amounts ranging from 0.01% to 2% by weight of the composition.
Compositions of the present invention may also contain vitamins.
Illustrative water-soluble vitamins are Niacinamide, Vitamin B 2 Vitamin B6, Vitamin C and Biotin. Among the useful water-insoluble vitamins are vitamin A (retinol), Vitamin A Palmitate, ascorbyl tetraisopalmitate, Vitamin E (tocopherol), Vitamin E Acetate and DLpanthenol. Total amount of vitamins when present in compositions according to the present invention may range from 0.001 to preferably from 0.01% to optimally from 0.1 to 0.5% by weight of the composition.
Desquamation agents are further optional components. Illustrative are the alpha-hydroxycarboxylic acids and beta-hydroxycarboxylic acids and salts of these acids. Among the former are salts of glycolic acid, lactic acid and malic acid. Salicylic acid is representative of the beta-hydroxycarboxylic acids. Amounts of these materials when present may range from about 0.1 to about by weight of the composition.
WO 2005/070384 PCT/EP2005/000436 A variety of herbal extracts may optionally be included in compositions of this invention. Illustrative are pomegranate, white birch (Betula Alba), green tea, chamomile, licorice and extract combinations thereof. The extracts may either be water soluble or water-insoluble carried in a solvent which respectively is hydrophilic or hydrophobic. Water and ethanol are the preferred extract solvents.
Except in the operating and comparative examples, or where otherwise explicitly indicated, all numbers in this description indicating amounts of material ought to be understood as modified by the word "about".
The term "comprising" is meant not to be limiting to any subsequently stated elements but rather to encompass non-specified elements of major or minor functional importance. In other words the listed steps, elements or options need not be exhaustive.
Whenever the words "including" or "having" are used, these terms are meant to be equivalent to "comprising" as defined above.
All documents referred to herein, including all patents, patent applications, and printed publications, are hereby incorporated by reference in their entirety in this disclosure.
The following examples will more fully illustrate the embodiments of this invention. All parts, percentages and proportions referred to herein and in the appended claims are by weight unless otherwise illustrated.
WO 2005/070384 PCT/EP2005/000436 Example 1 A series of formulas were investigated to evaluate the optical property contributions of silicone elastomer, zinc oxide and taurate polymer. These are recorded in Table I below.
TABLE I Sample No. (Weight Component INCI/Chemical Name 1 2 3 4 5 6 7 Surfactant Gel Tween 4 0 0 Polysorbate 40 1.62 1.62 1.62 1.62 1.62 1.62 1.62 LanetteG 16 Cety1 alcohol 1.55 1.55 1.55 1.55 1.55 1.55 1.55 Cutina® GMS Glycerin monostearate 0.78 0.78 0.78 0.78 0.78 0.78 0.78 Emersol" 315 Linoleic acid 0.10 0.10 0.10 0.10 0.10 0.10 0.10 PristereneO 9559 Stearic acid 0.25 0.25 0.25 0.25 0.25 0.25 0.25 Cholesterol NF Cholesterol 0.20 0.20 0.20 0.20 0.20 0.20 0.20 Humectant/emollient Glycerin 9.0 0 9.00 9.00 9.00 9.00 9.00 9.00 Sunscreen DermablockO OS Ethy-hexyl salicylate 2.00 2.00 2.00 2.00 2.00 2.00 2.00 Parsol" MCX Ethylhexyl methoxycinnamate 4.00 4.00 4.00 4.00 4.00 4.00 4.00 Oil Phase Dow Corning 200 Dimethicone 1.00 1.00 1.00 1.00 1.00 1.00 1.00 cSt) Dow Corning 245 Cyclopentasiloxane 20.00 Dow Corning 5225C Formulation aid 0.50 0.50 0.50 0.50 0.50 0.50 0.50 Dow Corning 9045 Silicone elastomer 20.00 20.00 20.00 20.00 20.00 20.00 Polymer Aristoflex® AVC ITaurate copolymer 0.80 0.80 0.80 0.80 0.80 0.40 0.60 Particulates Z-Cote" HP1 Zinc oxide 3.08 3.08 3.08 3.08 3.08 3.08 Dispersion ZnO) GanzpearlO GMP-0820 Polymethylmethacrylate 0.50 0.50 0.50 0.50 0.50 0.50 Satin Mica Mica 0.50 0.50 0.50 0.50 0.50 0.50 Timiron® MP 111 Titanium dioxide coated 1.00 1.00 1.00 1.00 1.00 1.00 1.00 mica Water 53.12 53.12 56.20 53.62 53.62 53.52 53.32 WO 2005/070384 PCT/EP2005/000436 28 Optical Measurements Opacity is the measure of intensity attenuation of a transmitted light beam shone perpendicular to a medium or film. The higher the direct beam attenuation, the greater will be the opacity.
The source of the light beam attenuation is two fold: A) Some of the original light is reflected back from the film/medium.
This gives the film/medium a true white/opaque appearance with great hiding power. using pigment-grade TiO 2 in a formulation will give the effect. B) Some of the light is deflected from the straight beam path but still transmitted through the film/medium. In effect, the film/medium goes from being transparent to translucent, creating a "blurred" image. Another term for this is soft focus.
Procedure: Apply (or draw down) a 3 mil (76.2 tm) film of a formulation using a draw down bar on to a plastic overhead transparency sheet. Let the film dry for 2 hours at room temperature. Take the coated overhead transparency and place it in an Instrument Systems goniospectrophotometer. Set the light source and detector arrayed in a straight line perpendicular to the coated transparency. The light source (set at 209 million Watt-nm/cm 2 which serves as a reference for all Transmission Intensity Values reported herein) is turned on and the measurement of the transmitted light intensity is made. Further measurements are made by moving the detector 10, 30, 40, degrees away from the direct transmission normal. These values indicate the extent of soft focus light scattering. The Reflectance or "radiance" of a product is determined in the same WO 2005/070384 PCT/EP2005/000436 29 way as opacity/soft focus light scattering, except for the positions of the light source and detector. The detector is degrees on one side of the normal/perpendicular, while the light source is 20 degrees on the other side. To determine the extent of the intensity attenuation, compare the intensity value to that of an uncoated overhead transparency. The difference between these two values is the extent of the attenuation or opacity.
Results: The effect of certain components on the optical properties of the compositions was evaluated by testing formulations with those components removed. Results are reported in Table II.
TABLE II Sample No. (Watt-nm/cm 2 Transmission 1 2 3 4 5 6 7 Acceptability Angle in Transmission degrees Intensity (Wattnm/cm 2 0 5M 10M 1GM S.1M 7.9M 10M 7.2M 4 to 7 million 1.1M 1.OM 1.6M 1.1m 1.2M 1.1M l.lm 1 to 2 million 128K 98K 104K 143K 131K 110K 116K 120 to 140 thousand 73K 56K 46K 80K 71K 63K 61K 60 to B0 thousand 48K 37K 25K 52K 45K 41K 45K 40 to 60 thousand Reflection Angle in degrees 154K 160K 195K 160K 131K 160K 155K 140 to 170 thousand Note; Bold values are outside the Acceptability range.
WO 2005/070384 PCT/EP2005/000436 31 Sample 1 is a preferred embodiment of the present invention.
Transmission Intensity (Opacity) at all angles and Reflection Intensity for this formula fell within the parameters necessary to achieve both soft focus and radiance. Replacement of the silicone elastomer (Dow Corning 9045) with cyclopentasiloxane (Dow Corning 245) in Sample 2 resulted in a Transmission Intensity at four angles outside the acceptability ranges. In Sample 3 the zinc oxide was omitted. Here the Transmission Intensity was also outside four of the acceptable ranges indicating the necessity of zinc oxide to achieve soft focus.
Removal of Ganzpearl® GMP-0820, which consists of polymethylmethacrylate beads, in Sample 4 had essentially no effect on the opacity. Sample 5 wherein Satin Mica was removed as expected demonstrated greater light transmission, but the Reflection Intensity and the 0° angle Transmission Intensity were outside the acceptable range. In Sample 6 the amount of Aristoflex AVC® (taurate copolymer) was halved. The 0° angle and 300 angle Transmission Intensity values were outside the acceptable range indicating that this copolymer had an influence and contributed to the soft focus effect. Sample 7 formulated with Aristoflex AVCo in amount between those of Samples 1 and 6 is a further example of how this copolymer is functionally important for soft focus.
Example 2 In this Example we investigated the effect of zinc oxide in contrast to titanium dioxide of essentially similar average particle sizes. The formulas investigated are recorded in Table III. Results are reported in Table IV.
TABLE III Sample No. (Weight I) Component INCI/CheicaL Name 8 9 10 11 Surfactat. Gel Tween@ 40 Polysorbate 40 1.62 1.62 1.62 1.62 Lanette® 16 Cetyl alcohol 1.55 1.55 1.55 1.55 Cutina® GMS Glycerin monostearate 0.78 0.78 0.78 0.78 Emersol® 315 Linoleic acid 0.1 0.1 0.1 0.1 Pristerene® 9559 Stearic acid 0.25 0.25 0.25 0.25 Cholesterol NF Cholesterol 0.20 0.2 0.2 0.2 Humectant/Emollient Glycerin I 9.0 9.0 9.0 Sunscreen Dermablock® OS Ethylhexyl salicylate 2.OD 2.0 2.0 Parsol® MCj Ethyihexyl methoxycinramate 4.00 4-0 4-0 Oil Phase Dow Corning 200 (50 cSt) Dimethicone 1.00 1.0 1.0 Dow Corning 245 Cyclopentasiloxane Dow Corning 5225C Formulation aid 0.50 0.50 C.50 0.50 Dow Coming 9040 Silicone elastomer 20.00 Dow Corning 9045 Silicone elastomer 20.00 20.00 20.00 Polymer Aristoflex® AVC ITaurate copolymer 0.80 0.80 0.80 0.80 Soft Focus Z-CoteO HP1 Dispersion (65% ZnO) Zinc oxide 3.08 TiO 2 (UV-grade) Titanium dioxide 3.08 1.5 0.4 .Ganzpearl GMP-0820 Polymethylmtnhacrylate 0.50 0.50 0.50 0.50 Satin Mica Mica Titirono MP 111 Titanium dioxide coated mica 0.50 0.50 0.50 0.50 Water 53.12 53.12 54.7 55.80 WO 2005/070384 PCT/EP2005/000436 33 TABLE IV Sample No. Transmission Intensity (million W-nm/cm) at 0 degree angle 8 5.1 9 2.3 11 On an equivalent weight basis Sample 8 provided a Transmission Intensity which was within the acceptability range. By contrast, the titanium dioxide formulated Sample Nos. 9, 10 and 11 exhibited Transmission Intensity values outside the acceptable range.
Example 3 A series of experiments were conducted to evaluate soft focus effects of a variety of different thickening polymers. The formulations which were evaluated are recorded in Table V.
TA13LE V Sample No. (Weight Cormponent INCI/Chcmical Name 12 13 14 15 16 17 18 Surifactant Gel Tween 40® Polysorbate 40 1.62 1.62 1.62 1.62 1.62 1.62 1.62 Lanetteoe 16 Cetyl alcohol 1-55 L-55 1.55 1.55 1.55 1.55 1.55 Cutina(D OMS Glycerin monostearate 0.78 0.78 0.78 0.78 0.78 0. 7 8 0-78 Emersole 315 Linoleic acid 0.10 0.10 0.10 0.10 0.10 0.10 0.10 PristereneO 9559 Stearic acid 0.25 0.25 0.25 0.25 0.25 0.25 0.25 Cholesterol NF Clholesterol. 0.20 0.20 0.20 0.20 0.20 0.20 0.20 Humectant/emollient Glycerin 9.00 9.00- 9.00 9.00 9.00 9.00 9.00 Sunscreen DermablockO OS Ethyihexyl salicylate 2.00 2.00 2.00 2.00 2.00 2.00 2.00 ParsolO MCX jEthyihexyl methoxycinnamate 4.00 4.00 4.00 4.00 4.00 4.00 4.00 Oil Phase Dow Corning 200 Dimethicone 1.00 1.00 1.00 1.00 1.00 1.00 1.00 cSt) flow Comning 245 Cyclopentasiloxane 20.00___ Dow Corning 5225C Formulation aid 0.50 0.50 0.50 0.50 0.50 0.50 0.50 Dow Comning 9045 Silicone elastoner 20.00 20.00 20.00 20.00 20.00 20.00_ Polymer Aristoflex* AVC Ammonium acryloyldimethyltaurate 0.80 Carbopol ETD 2020 Carbomer 0.80 FRhodopol 23 Xanthan gum 0.80 Viscolam AT 100/P Sodium acrylate/sodium acryloyldimethyltaurate 2.00 Salcare SC96 Polyquaternium 37 and propylene 15 Natroso.- Plus 330 CS Cety hydroxyethyl-cellulosa 0-80 Femulen TR-1 Acrylates/ClO-30 alkyl acrylate 08 TABLE V (Continued) Particulates Z-CoteO Dispersion Zinc oxide 3.08 3.08 3.08 3.08 3.08 3.08 3.08 ZnO) GanzpearlO GMP-0B20 Polymethylinethacryiate 0.50 0.50 0.50 0.50 0.50 0.50 0.50 Satin Mica Mica 0.50 0.50 0.50 0.50 0-50 0.50 0.50 Timirong MP Ii Titanium dioxide coated mica 1.00 1.00 1.00 1.00 1.00 1.00 1.00 water 53.12 i53.12 51.92 52.42 153.12 153.12 WO 2005/070384 PCT/EP2005/000436 36 Samples 13, 16 and 18 were all unstable with either initial phase separation (between oil and water) at 75 0 C or exhibited separation upon cooling. Thus, unsuitable polymers included Carbomer, Salcare SC96® and Pemulen TR-1.
TABLE VI Sample No. Normal Force 10,000 s Formulation Stability (grams) 12 70.6 Stable 13 61.5 Unstable 14 33.5 Stable 77.0 Stable 16 76.4 Unstable 17 43.7 Stable 18 34.0 Unstable Samples 12, 14, 15 and 17 were stable utilizing respectively Aristoflex AVC®, xanthan gum and Viscolam AT 100/P. However, the Transmission Intensity for the xanthan gum (Sample 14) was outside the Acceptability Range. See Table VII. The Viscolam AT® 100/P (Sodium Acrylate/Sodium Acryloyldimethyltaurate Copolymer) in Sample exhibited excellent Transmission Intensity Opacity at all angles and Reflection Intensity fell within the parameters necessary to achieve both soft focus and radiance.
WO 2005/070384 PCT/EP2005/000436 37 TABLE VII Sample No. (Watt-nm/cm 2 Transmission 12 14 15 17* Acceptability Angle in Transmission degrees Intensity (Wattnm/cm 2 0 5.5M 9.5M 5.1M 14.6M 4 to 7 million 1.1M 1.0M 1.1M 1.2M 1 to2 million 128K 107K 124K 84K 120 to 140 thousand 73K 59K 68K 49K 60 to 80 thousand 48K 39K 48K 34K 40 to 60 thousand Reflection Angle in degrees 154K 169K 162K 151K 140 to 170 thousand Note: Asterisk formulation gave a non-uniform/inconsistent film.
Bold Values are outside the Acceptability Range.
P \WPDOCSXPQ(XIWuly) 7 Jul _1 I26MA)I_ lu SoA dm27A)7A)(, 0 -37A- 1 C Throughout this specification and the claims which follow, unless the context requires otherwise, the word "comprise", 00 and variations such as "comprises" or "comprising", will be 0 5 understood to imply the inclusion of a stated integer or 0 step or group of integers or steps but not the exclusion of
IN
any other integer or step or group of integers or steps.
The reference in this specification to any prior publication (or information derived from it), or to any matter which is known, is not, and should not be taken as an acknowledgment or admission or any form of suggestion that that prior publication (or information derived from it) or known matter forms part of the common general knowledge in the field of endeavour to which this specification relates.

Claims (12)

1. A cosmetic composition comprising: a crosslinked silicone elastomer; 00 (ii) a zinc oxide or zirconium oxide of average particle size less than 300 nm; 0 (iii) a taurate polymer; (iv) a light reflecting inorganic platelet-shaped particle selected from titanium dioxide coated mica or bismuth oxychloride and having an average particle §size of 10,000 to 30,000 nm; and a cosmetically acceptable carrier system.
2. The composition according to claim 1 wherein the taurate polymer is a copolymer of acryloyl dimethyl taurate and a monomer selected from the group consisting of styrene, acrylic acid, methacrylic acid, vinyl chloride, vinyl acetate, vinyl pyrrolidone, isoprene, vinyl alcohol, vinyl methylether, chloro-styrene, dialkylamino-styrene, maleic acid, acrylamide, methacrylamide and mixtures thereof.
3. The composition according to claim 2 wherein the taurate polymer us Acryloyl Dimethyltaurate/Vinyl Pyrrolidone Copolymer.
4. The composition according to claim 1 further comprising crystalline structurant formed by a surfactant and a co-surfactant in a relative weight ratio and type of material defined by an enthalpy ranging from 2 to 15 Joules per gram as measured by Differential Scanning Calorimetry.
The composition according to claim 1 having a normal force ranging from +5 to +100 grams.
6. The composition according to claim 5 wherein the normal force ranges from +25 to grams. P \WPDOCS\SLCSpc \I 26,8(4X6PU n dSPA do 00 O -39- S
7. The composition according to claim 1 further comprising from 0.01 to 10% by weight Sof hollow particles of polymethylmethacrylate. 00
8. The composition according to claim 1 further comprising from 0.05 to about 2% of a non-coated mica of average (volume) particle size ranging from 1,000 to 10,000 nm. 00
9. The composition according o any preceding claim having a Transmission Intensity of S4 to 7 million watt-nm/cm 2 measured at an angle of a Transmission Intensity ranging from 1 to 2 million watt-nm/cm 2 measured at a 100 angle; a Transmission Intensity ranging from 120 to 140 thousand watt-nm/cm 2 measured at a 300 angle; a Transmission Intensity ranging from 60 to 80 thousand watt-nm/cm 2 measured at a 400 angle; and a Transmission Intensity ranging from 40 to 60 thousand watt-nm/cm 2 measured at a 500 angle.
A composition according to claim 9 wherein the composition has a Reflection Intensity ranging from 140 to 170 thousand watt-nm/cm 2 measured at a 300 angle.
11. A cosmetic composition comprising: from 0.01 to 30% of a crosslinked silicone elastomer by weight of the composition; (ii) from 0.1 to 20% of a zinc oxide by weight of the composition, the zinc oxide having an average particle size less than 300 nm; (iii) from 0.001 to 10% of a taurate polymer by weight of the composition; (iv) a light reflecting inorganic platelet-shaped particle selected from titanium dioxide coated mica or bismuth oxychloride and having an average particle size of 10,000 to 30,000 nm; and a cosmetically acceptable carrier system; and wherein the composition has a Transmission Intensity of 4 to 7 million watt-nm/cm 2 measured at an angle of 00; a Transmission Intensity ranging from 1 to 2 million watt- nm/cm 2 measured at a 100 angle; a Transmission Intensity ranging from 120 to 140 thousand watt-nm/cm 2 measured at a 300 angle; a Transmission Intensity ranging P \WPDOCSSLCWcI\I2WX)I _Un.Ac-2dSPAdc 00 O from 60 to 80 thousand watt-nm/cm 2 measured at a 400 angle; and a Transmission c, Intensity ranging from 40 to 60 thousand watt-nm/cm 2 measured at a 500 angle. S
12. A cosmetic composition substantially as hereinbefore described with reference to the 00 In ot'
AU2005205898A 2004-01-23 2005-01-12 Taurate formulated pigmented cosmetic composition exhibiting radiance with soft focus Ceased AU2005205898B8 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53866404P 2004-01-23 2004-01-23
US60/538,664 2004-01-23
PCT/EP2005/000436 WO2005070384A1 (en) 2004-01-23 2005-01-12 Taurate formulated pigmented cosmetic composition exhibitiing radiance with soft focus

Publications (3)

Publication Number Publication Date
AU2005205898A1 AU2005205898A1 (en) 2005-08-04
AU2005205898B2 true AU2005205898B2 (en) 2008-05-08
AU2005205898B8 AU2005205898B8 (en) 2008-05-29

Family

ID=34807207

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005205898A Ceased AU2005205898B8 (en) 2004-01-23 2005-01-12 Taurate formulated pigmented cosmetic composition exhibiting radiance with soft focus

Country Status (7)

Country Link
JP (1) JP2007518761A (en)
AR (1) AR047737A1 (en)
AU (1) AU2005205898B8 (en)
BR (1) BRPI0506504A (en)
TW (1) TW200536569A (en)
WO (1) WO2005070384A1 (en)
ZA (1) ZA200605884B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070092457A1 (en) * 2005-10-24 2007-04-26 Librizzi Joseph J Compositions comprising polymeric emulsifiers and methods of using the same
FR2910284B1 (en) * 2006-12-20 2009-04-17 Oreal COSMETIC PRODUCT COMPRISING SILICONE COMPOUNDS AND AN AMPHIPHILIC POLYMER
US9345649B2 (en) 2006-12-21 2016-05-24 Avon Products, Inc. Cosmetic composition containing novel fractal particle-based gels
TWI411448B (en) 2007-12-27 2013-10-11 Avon Prod Inc Optical blurring pigment composition suitable for use in cosmetics
TWI468185B (en) * 2007-12-27 2015-01-11 Avon Prod Inc Gel technology suitable for use in cosmetic compositions
EP2262469A4 (en) * 2008-04-15 2013-12-04 Immanence Integrale Dermo Correction Inc Skin care compositions and methods of use thereof
EP2456413B1 (en) * 2009-07-20 2017-06-21 L'Oréal Emulsion containing a bismuth oxychloride dispersion
US8933134B2 (en) 2010-06-09 2015-01-13 L'oreal Compositions containing agar and a softening agent
FR2975905B1 (en) * 2011-05-31 2013-06-28 Lvmh Rech COSMETIC COMPOSITION FOR CARE OR MAKE-UP CONTAINING POWDERS AND METHOD OF MANUFACTURE
WO2014019840A2 (en) * 2012-08-01 2014-02-06 Dow Corning Corporation Aqueous silicone dispersions and their preparation
FR3002449B1 (en) 2013-02-25 2015-04-03 Oreal COSMETIC COMPOSITION OF GEL TYPE
FR3021533B1 (en) 2014-05-28 2017-09-15 Oreal COSMETIC COMPOSITION OF GEL TYPE
JP6567262B2 (en) * 2014-09-30 2019-08-28 小林製薬株式会社 Composition for external use
FR3061004B1 (en) * 2016-12-28 2019-08-16 L V M H Recherche UNIVERSAL COSMETIC COMPOSITION

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020155076A1 (en) * 2000-12-23 2002-10-24 Ghita Lanzendorfer Gel creams in the form of O/W emulsions containing one or more ammonium acryloyldimethyltaurate/vinylpyrrolidone copolymers
WO2003022236A1 (en) * 2001-09-12 2003-03-20 Unilever Plc Thickened cosmetic compositions comprising a taurate copolymer
FR2834450A1 (en) * 2002-01-04 2003-07-11 Oreal Composition useful for cosmetic purposes comprises an aqueous dispersion of silicone copolymer particles containing a sulfonic acid polymer and/or an organic powder
WO2003099253A1 (en) * 2002-05-29 2003-12-04 Unilever Plc Personal care compositions with hydroxy amine neutralized polymers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5798205A (en) * 1980-12-09 1982-06-18 Pola Chem Ind Inc Cosmetic giving durable make-up
FR2751542B1 (en) * 1996-07-29 1998-09-11 Oreal SKIN OR HAIR PROTECTION COMPOSITION CONTAINING NANOPIGMENTS AND AN ELASTOMERIC SOLID ORGANOPOLYSILOXANE ASSOCIATED WITH A FATTY PHASE
FR2787460A1 (en) * 1998-12-18 2000-06-23 Oreal STABLE COSMETIC COMPOSITION COMPRISING A POLY POLYMER (2-ACRYLAMIDO 2-METHYL-PROPANE SULFONIC), UNCOATED SOLID PARTICLES AND AN OIL-DISPERSANT POLYMER
FR2794125B1 (en) * 1999-05-26 2001-07-20 Oreal COMPOSITION IN THE FORM OF AN OIL-IN-WATER EMULSION AND ITS USES, IN PARTICULAR COSMETICS
DE60210737T2 (en) * 2002-01-04 2007-01-18 L'oreal S.A. A silicone copolymer and either a polymer of an ethylenically unsaturated monomer having sulfonic groups or an organic powder-containing composition; their uses, especially in cosmetics
DE10250755B4 (en) * 2002-10-31 2007-02-08 Merz Pharma Gmbh & Co. Kgaa A foamable composition based on an O / W emulsion comprising a combination of a silicone-based emulsifier and an anionic surfactant having improved skin action, their preparation and their use
FR2853535B1 (en) * 2003-04-14 2006-07-14 Oreal PHOTOPROTECTIVE COMPOSITION COMPRISING AT LEAST ONE ACRYLAMIDO-2-METHYL PROPANE SULFONIC ACID POLYMER AND A 4,4-DIARYLBUTADIENE, USES

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020155076A1 (en) * 2000-12-23 2002-10-24 Ghita Lanzendorfer Gel creams in the form of O/W emulsions containing one or more ammonium acryloyldimethyltaurate/vinylpyrrolidone copolymers
WO2003022236A1 (en) * 2001-09-12 2003-03-20 Unilever Plc Thickened cosmetic compositions comprising a taurate copolymer
FR2834450A1 (en) * 2002-01-04 2003-07-11 Oreal Composition useful for cosmetic purposes comprises an aqueous dispersion of silicone copolymer particles containing a sulfonic acid polymer and/or an organic powder
WO2003099253A1 (en) * 2002-05-29 2003-12-04 Unilever Plc Personal care compositions with hydroxy amine neutralized polymers

Also Published As

Publication number Publication date
ZA200605884B (en) 2008-05-28
AU2005205898A1 (en) 2005-08-04
JP2007518761A (en) 2007-07-12
TW200536569A (en) 2005-11-16
AR047737A1 (en) 2006-02-15
WO2005070384A1 (en) 2005-08-04
BRPI0506504A (en) 2007-02-27
AU2005205898B8 (en) 2008-05-29

Similar Documents

Publication Publication Date Title
AU2004314132B2 (en) Pigmented cosmetic composition exhibiting radiance with soft focus
AU2005205898B8 (en) Taurate formulated pigmented cosmetic composition exhibiting radiance with soft focus
US20050249684A1 (en) Taurate formulated pigmented cosmetic composition exhibiting radiance with soft focus
CA2671097C (en) Single-crystal platy barium sulfate in cosmetic compositions
AU2009216883B2 (en) Cationic copolymers formulated with pigmented cosmetic compositions exhibiting radiance with soft focus

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 22, NO 18, PAGE(S) 2224 UNDER THE HEADING APPLICATIONS ACCEPTED -NAME INDEX UNDER THE NAME UNILEVER PLC, APPLICATION NO. 2005205898, UNDER INID (54), CORRECT THE TITLE OF THE INVENTION TO TAURATE FORMULATED PIGMENTED COSMETIC COMPOSITION EXHIBITING RADIANCE WITH SOFT FOCUS

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired